Skip to main content
search

Preclinical

Sign up

Latest resources

Featured resource

Upcoming preclinical webinars

Latest preclinical blogs

Meet our experts at the following events

Conference

Redefining Every Stage of Investment (RESI) Seed to Exit

December 4, 2025 – London, UK
Conference

JSCPT 2025

December 5 - 6, 2025 – Tokyo, Japan
Conference

JPM 2026 44th Annual Healthcare Conference & Biotech Showcase

January 12 - 16, 2026 – San Francisco, CA

All preclinical resources

A Guide to the FDA Announcement to Phase Out Animal Testing for Drugs

Certara Services, Model Informed Drug Development, New Approach Methodologies (NAMs), Guide

From Insight to Impact: Certainty EMEA 2025

Certara Products, Certara Services, Blog

Quantitative Systems Pharmacology Modeling to Support the Preclinical Development of Radiopharmaceuticals

Certara Products - Certara IQ, Modeling and Simulation - QSP, Blog

Using M&S to Evaluate Oncology Drug Dosing

Clinical Pharmacology, Model Informed Drug Development, Modeling and Simulation, Modeling and Simulation - PBPK, Modeling and Simulation - PK/PD, Modeling and Simulation - QSP, Oncology/Hematology, Therapeutic Specialties, Blog

ACoP 2025 Insights: Scaling the Future of QSP Modeling with Certara IQ™

Certara Products, Certara Products - Certara IQ, Certara Products - Phoenix, Certara Services, Model Informed Drug Development, Modeling and Simulation, Modeling and Simulation - PBPK, Modeling and Simulation - PK/PD, Modeling and Simulation - QSP, Blog

Seeing Across Species: Empiric Pharmacokinetic Time-Course Scaling in Phoenix®

Certara Products - Phoenix, Drug Development, Modeling and Simulation - PK/PD, Webinar

Build investor confidence with science-backed strategy

Certara Services, Fact Sheet

Failure to Launch: Building Smarter Strategies to Get the Right Drug to the Right Patient

Certara Services, Drug Development, Webinar

Empowering the PK Community: Insights from the Phoenix® User Events

Modeling and Simulation - PK/PD, Blog

Key Lessons & Opportunities in applying NCA and PopPK to ADCs

Biologics, Certara Services, Drug Development, Model Informed Drug Development, Modeling and Simulation, Modeling and Simulation - PBPK, Modeling and Simulation - PK/PD, Pharmacometrics, Blog

Bottlenecks to Breakthroughs: Tackling Challenges in QSP Modeling

Certara Products - Certara IQ, Model Informed Drug Development, Modeling and Simulation, Modeling and Simulation - QSP, Blog

Pregnant women, long excluded from drug trials, are back in the spotlight

Certara Products - Simcyp, Modeling and Simulation - PBPK, Press Coverage
Sign up to newsletter

Why sign up? Because transforming drug development is not just our goal—it’s our obsession. If it’s yours too, then be the first to know of new insights and join us in pushing the boundaries of science.